Reaction
Chronic Hepatic Failure reporting signals
As of the last recalculation, Chronic Hepatic Failure appears in 644 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is RIFAXIMIN (PRR 165.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Rifaximin | 92 | 165.4 | 166.2 |
| Lactulose | 59 | 54.7 | 54.7 |
| Ursosiol | 14 | 23.8 | 23.8 |
| Selexipag | 18 | 23.1 | 23.2 |
| Ursodiol | 14 | 21.2 | 21.2 |
| Sofosbuvir | 12 | 20.0 | 20.0 |
| Entecavir | 6 | 16.8 | 16.8 |
| Tenofovir Disoproxil Fumarate Tablets | 4 | 15.1 | 15.1 |
| Ribavirin | 25 | 13.0 | 13.0 |
| Romiplostim | 6 | 13.0 | 13.0 |
| Velpatasvir And Sofosbuvir | 4 | 10.1 | 10.1 |
| Ledipasvir And Sofosbuvir | 5 | 8.5 | 8.5 |
| Ambrisentan | 29 | 7.8 | 7.8 |
| Elexacaftor, Tezacaftor, And Ivacaftor | 3 | 7.8 | 7.8 |